

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 7.53090955 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.53090955 |
| 3 | sarcomere organization (GO:0045214) | 7.21067140 |
| 4 | plasma membrane repair (GO:0001778) | 6.46022236 |
| 5 | actin-mediated cell contraction (GO:0070252) | 6.18474288 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 6.10546967 |
| 7 | cardiac myofibril assembly (GO:0055003) | 6.02048277 |
| 8 | myofibril assembly (GO:0030239) | 5.96443283 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.71947043 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.05389473 |
| 11 | actin filament-based movement (GO:0030048) | 5.00491637 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.99377532 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.99377532 |
| 14 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.73917658 |
| 15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.71072295 |
| 16 | actomyosin structure organization (GO:0031032) | 4.68730861 |
| 17 | skeletal muscle contraction (GO:0003009) | 4.54497215 |
| 18 | cardiac muscle contraction (GO:0060048) | 4.49694409 |
| 19 | response to peptidoglycan (GO:0032494) | 4.48816619 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.44530248 |
| 21 | cardiac muscle cell development (GO:0055013) | 4.42989185 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36903862 |
| 23 | detection of other organism (GO:0098543) | 4.34767448 |
| 24 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.34311192 |
| 25 | striated muscle contraction (GO:0006941) | 4.34251771 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33818667 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.28981397 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 4.22147695 |
| 29 | detection of bacterium (GO:0016045) | 4.19425995 |
| 30 | cardiac cell development (GO:0055006) | 4.15420909 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 4.13421694 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 4.11460367 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.04812107 |
| 34 | skeletal muscle adaptation (GO:0043501) | 3.98651015 |
| 35 | carnitine shuttle (GO:0006853) | 3.90622353 |
| 36 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.89629630 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86408920 |
| 38 | regulation of actin filament-based movement (GO:1903115) | 3.84367701 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.83225190 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.71522506 |
| 41 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.71129447 |
| 42 | cellular extravasation (GO:0045123) | 3.67772147 |
| 43 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.63380233 |
| 44 | cardiac muscle hypertrophy (GO:0003300) | 3.61856934 |
| 45 | germinal center formation (GO:0002467) | 3.61332771 |
| 46 | striated muscle atrophy (GO:0014891) | 3.57257335 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.56427116 |
| 48 | regulation of cell communication by electrical coupling (GO:0010649) | 3.56230769 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.54935579 |
| 50 | regulation of striated muscle contraction (GO:0006942) | 3.53600145 |
| 51 | adult heart development (GO:0007512) | 3.53064703 |
| 52 | tricarboxylic acid cycle (GO:0006099) | 3.50475014 |
| 53 | positive regulation of myotube differentiation (GO:0010831) | 3.49786319 |
| 54 | striated muscle hypertrophy (GO:0014897) | 3.48638057 |
| 55 | regulation of sarcomere organization (GO:0060297) | 3.48319084 |
| 56 | leukocyte aggregation (GO:0070486) | 3.46983884 |
| 57 | muscle tissue morphogenesis (GO:0060415) | 3.46766274 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45872508 |
| 59 | fatty acid transmembrane transport (GO:1902001) | 3.45571282 |
| 60 | heart trabecula formation (GO:0060347) | 3.43258391 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40688870 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35726764 |
| 63 | muscle contraction (GO:0006936) | 3.30920134 |
| 64 | regulation of sequestering of triglyceride (GO:0010889) | 3.29404380 |
| 65 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.26425494 |
| 66 | muscle hypertrophy (GO:0014896) | 3.26189583 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.26158341 |
| 68 | heart process (GO:0003015) | 3.25981308 |
| 69 | heart contraction (GO:0060047) | 3.25981308 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 3.23661827 |
| 71 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.23570755 |
| 72 | detection of biotic stimulus (GO:0009595) | 3.23285931 |
| 73 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.22856866 |
| 74 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15268045 |
| 75 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.14798796 |
| 76 | striated muscle adaptation (GO:0014888) | 3.14659563 |
| 77 | cytidine metabolic process (GO:0046087) | 3.14329057 |
| 78 | cytidine catabolic process (GO:0006216) | 3.14329057 |
| 79 | cytidine deamination (GO:0009972) | 3.14329057 |
| 80 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12636284 |
| 81 | response to host (GO:0075136) | 3.10689681 |
| 82 | response to host defenses (GO:0052200) | 3.10689681 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.10689681 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.09435004 |
| 85 | response to host immune response (GO:0052572) | 3.09435004 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 3.09211017 |
| 87 | muscle system process (GO:0003012) | 3.09105012 |
| 88 | positive thymic T cell selection (GO:0045059) | 3.08341513 |
| 89 | regulation of p38MAPK cascade (GO:1900744) | 3.08307369 |
| 90 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07104214 |
| 91 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.06979376 |
| 92 | carnitine transmembrane transport (GO:1902603) | 3.05418594 |
| 93 | regulation of necroptotic process (GO:0060544) | 3.05384528 |
| 94 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04398974 |
| 95 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04040104 |
| 96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01403924 |
| 97 | regulation of the force of heart contraction (GO:0002026) | 3.00836225 |
| 98 | mannose metabolic process (GO:0006013) | 2.99897368 |
| 99 | striated muscle cell development (GO:0055002) | 2.99761435 |
| 100 | muscle atrophy (GO:0014889) | 2.98949480 |
| 101 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.98268795 |
| 102 | neutrophil activation (GO:0042119) | 2.97805479 |
| 103 | B cell receptor signaling pathway (GO:0050853) | 2.97796308 |
| 104 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.97361963 |
| 105 | muscle adaptation (GO:0043500) | 2.96783397 |
| 106 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.95781205 |
| 107 | macrophage activation (GO:0042116) | 2.95581129 |
| 108 | respiratory burst (GO:0045730) | 2.95390853 |
| 109 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.94809281 |
| 110 | negative regulation of heart growth (GO:0061117) | 2.94809281 |
| 111 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93296823 |
| 112 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.92611846 |
| 113 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91507199 |
| 114 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.90477664 |
| 115 | negative regulation of cell size (GO:0045792) | 2.90110438 |
| 116 | granulocyte activation (GO:0036230) | 2.87250287 |
| 117 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86715129 |
| 118 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84578801 |
| 119 | myeloid cell activation involved in immune response (GO:0002275) | 2.84093244 |
| 120 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82519308 |
| 121 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82519308 |
| 122 | modulation by symbiont of host immune response (GO:0052553) | 2.82519308 |
| 123 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82519308 |
| 124 | modulation by symbiont of host defense response (GO:0052031) | 2.82519308 |
| 125 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82519308 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.82329973 |
| 127 | response to muscle activity (GO:0014850) | 2.82149018 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80647841 |
| 129 | response to inactivity (GO:0014854) | 2.80044970 |
| 130 | response to type I interferon (GO:0034340) | 2.78801982 |
| 131 | apoptotic cell clearance (GO:0043277) | 2.78399345 |
| 132 | microglial cell activation (GO:0001774) | 2.77051389 |
| 133 | regulation of T cell tolerance induction (GO:0002664) | 2.76841543 |
| 134 | cellular response to type I interferon (GO:0071357) | 2.76755372 |
| 135 | type I interferon signaling pathway (GO:0060337) | 2.76755372 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75135129 |
| 137 | skeletal muscle tissue regeneration (GO:0043403) | 2.75043602 |
| 138 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74654688 |
| 139 | creatine metabolic process (GO:0006600) | 2.74471792 |
| 140 | regulation of tolerance induction (GO:0002643) | 2.74238605 |
| 141 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74105227 |
| 142 | positive regulation of B cell differentiation (GO:0045579) | 2.73768105 |
| 143 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73348126 |
| 144 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72728209 |
| 145 | muscle fiber development (GO:0048747) | 2.72686767 |
| 146 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.72459885 |
| 147 | defense response to protozoan (GO:0042832) | 2.71619673 |
| 148 | carnitine transport (GO:0015879) | 2.70989300 |
| 149 | amino-acid betaine transport (GO:0015838) | 2.70989300 |
| 150 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.69864822 |
| 151 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.68700061 |
| 152 | negative regulation of muscle hypertrophy (GO:0014741) | 2.66936072 |
| 153 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.66703491 |
| 154 | regulation of muscle contraction (GO:0006937) | 2.66572511 |
| 155 | negative thymic T cell selection (GO:0045060) | 2.66522031 |
| 156 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.63461604 |
| 157 | response to laminar fluid shear stress (GO:0034616) | 2.62977800 |
| 158 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62413013 |
| 159 | T cell selection (GO:0045058) | 2.59919344 |
| 160 | cardiac muscle adaptation (GO:0014887) | 2.59043032 |
| 161 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.59043032 |
| 162 | muscle hypertrophy in response to stress (GO:0003299) | 2.59043032 |
| 163 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58939742 |
| 164 | T-helper 1 type immune response (GO:0042088) | 2.57957531 |
| 165 | thymic T cell selection (GO:0045061) | 2.56781721 |
| 166 | cell-substrate junction assembly (GO:0007044) | 2.56139138 |
| 167 | muscle cell development (GO:0055001) | 2.55699087 |
| 168 | skeletal muscle fiber development (GO:0048741) | 2.55500504 |
| 169 | negative regulation of potassium ion transport (GO:0043267) | 2.54335513 |
| 170 | positive regulation of cation channel activity (GO:2001259) | 2.54185360 |
| 171 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.53943727 |
| 172 | regulation of antigen processing and presentation (GO:0002577) | 2.53876430 |
| 173 | regulation of fatty acid oxidation (GO:0046320) | 2.53111423 |
| 174 | response to protozoan (GO:0001562) | 2.52938951 |
| 175 | positive regulation of mast cell activation (GO:0033005) | 2.52907696 |
| 176 | regulation of macrophage cytokine production (GO:0010935) | 2.52516864 |
| 177 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.52106895 |
| 178 | negative regulation of necroptotic process (GO:0060546) | 2.52056630 |
| 179 | membrane raft organization (GO:0031579) | 2.52035145 |
| 180 | response to interleukin-15 (GO:0070672) | 2.51809768 |
| 181 | negative regulation of innate immune response (GO:0045824) | 2.50378158 |
| 182 | regulation of B cell differentiation (GO:0045577) | 2.50219484 |
| 183 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.49800845 |
| 184 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.49577781 |
| 185 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.49164097 |
| 186 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49036901 |
| 187 | negative T cell selection (GO:0043383) | 2.48310557 |
| 188 | regulation of mast cell activation (GO:0033003) | 2.47089613 |
| 189 | regulation of regulated secretory pathway (GO:1903305) | 2.46458911 |
| 190 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.45770469 |
| 191 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.45366496 |
| 192 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44656776 |
| 193 | T cell migration (GO:0072678) | 2.44529970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.63082431 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.93754524 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.07446585 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.03074762 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60827277 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60379329 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.59825291 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.44805954 |
| 9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.44805954 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25881389 |
| 11 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.25557570 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20747935 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19627572 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17145447 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16597440 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16536618 |
| 17 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.16431849 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16082497 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.06408678 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04786626 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01583783 |
| 22 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01130741 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98394069 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96427099 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95274048 |
| 26 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.94851861 |
| 27 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.90054794 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89833387 |
| 29 | * MAF_26560356_Chip-Seq_TH1_Human | 1.86452184 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85881399 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82729648 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82724555 |
| 33 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79500138 |
| 34 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.78254092 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75698553 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75109605 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69643149 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69632408 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62241620 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61383746 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60593332 |
| 42 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.60291250 |
| 43 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59845636 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59199744 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.58772816 |
| 46 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58031447 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57118647 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54042199 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53609271 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51174638 |
| 51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.49779653 |
| 52 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.49773080 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.49617239 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48025134 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47634940 |
| 56 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.47385508 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45930997 |
| 58 | * MYB_26560356_Chip-Seq_TH1_Human | 1.45673180 |
| 59 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.45491828 |
| 60 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44439556 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43650440 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42784790 |
| 63 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.41245823 |
| 64 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34816992 |
| 65 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34222950 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33938910 |
| 67 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32582107 |
| 68 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30760123 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30068560 |
| 70 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.29780900 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.29065981 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28731574 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28212780 |
| 74 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.27471115 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26702882 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26529360 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.25752189 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25735362 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25589373 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24684702 |
| 81 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22946937 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22471070 |
| 83 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21527369 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21217567 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20951622 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20335713 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18861682 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18332685 |
| 89 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17605550 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16141909 |
| 91 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15430044 |
| 92 | MYB_26560356_Chip-Seq_TH2_Human | 1.15413358 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14856530 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14224839 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12056663 |
| 96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11896678 |
| 97 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11514777 |
| 98 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09931847 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09892692 |
| 100 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09748855 |
| 101 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09725020 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09006227 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08915589 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07795196 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07504872 |
| 106 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06779061 |
| 107 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04483543 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04483543 |
| 109 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04331686 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04104105 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04090782 |
| 112 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03666784 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03352165 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02757682 |
| 115 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02485462 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01899837 |
| 117 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01641861 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01561193 |
| 119 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01538225 |
| 120 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01052987 |
| 121 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00944234 |
| 122 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00589953 |
| 123 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00440757 |
| 124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00151801 |
| 125 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96788938 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95048970 |
| 127 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.94873768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.51315923 |
| 2 | MP0000751_myopathy | 4.36319390 |
| 3 | MP0003646_muscle_fatigue | 4.07675198 |
| 4 | MP0000749_muscle_degeneration | 4.03541602 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.86461729 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.12001962 |
| 7 | MP0003724_increased_susceptibility_to | 3.02314935 |
| 8 | MP0005451_abnormal_body_composition | 3.00301817 |
| 9 | MP0000750_abnormal_muscle_regeneration | 2.89337264 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.87155888 |
| 11 | MP0005330_cardiomyopathy | 2.81742477 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.77866245 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.68951968 |
| 14 | MP0004510_myositis | 2.59968304 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.48316768 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.37823732 |
| 17 | MP0004130_abnormal_muscle_cell | 2.35326484 |
| 18 | MP0002972_abnormal_cardiac_muscle | 2.24088848 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.20541662 |
| 20 | MP0000759_abnormal_skeletal_muscle | 2.18970882 |
| 21 | MP0000747_muscle_weakness | 2.17728378 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.14895496 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.13037429 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.09654800 |
| 25 | MP0008260_abnormal_autophagy | 2.08194609 |
| 26 | MP0003828_pulmonary_edema | 2.05257074 |
| 27 | MP0002269_muscular_atrophy | 2.05086095 |
| 28 | MP0006082_CNS_inflammation | 2.04446982 |
| 29 | MP0005369_muscle_phenotype | 1.97399191 |
| 30 | MP0002723_abnormal_immune_serum | 1.96883250 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.94941843 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.90836228 |
| 33 | MP0005671_abnormal_response_to | 1.90298306 |
| 34 | MP0005385_cardiovascular_system_phenoty | 1.89822648 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 1.89822648 |
| 36 | MP0003279_aneurysm | 1.88235372 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.86956305 |
| 38 | MP0004947_skin_inflammation | 1.84367848 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.81788964 |
| 40 | MP0003303_peritoneal_inflammation | 1.78166205 |
| 41 | MP0004484_altered_response_of | 1.67023012 |
| 42 | MP0000733_abnormal_muscle_development | 1.65535420 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.61294407 |
| 44 | MP0000343_altered_response_to | 1.59354516 |
| 45 | MP0005275_abnormal_skin_tensile | 1.54002043 |
| 46 | MP0002398_abnormal_bone_marrow | 1.48459432 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.47844016 |
| 48 | MP0000858_altered_metastatic_potential | 1.46511465 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44986859 |
| 50 | MP0006138_congestive_heart_failure | 1.44594773 |
| 51 | MP0000716_abnormal_immune_system | 1.44096404 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.43769604 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.43033834 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.41438055 |
| 55 | MP0005670_abnormal_white_adipose | 1.40350887 |
| 56 | MP0009840_abnormal_foam_cell | 1.39635365 |
| 57 | MP0003137_abnormal_impulse_conducting | 1.39224941 |
| 58 | MP0003950_abnormal_plasma_membrane | 1.38472248 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.32934594 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.30064455 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.29939451 |
| 62 | MP0004233_abnormal_muscle_weight | 1.25036499 |
| 63 | MP0008469_abnormal_protein_level | 1.22481677 |
| 64 | MP0001958_emphysema | 1.21671787 |
| 65 | MP0003436_decreased_susceptibility_to | 1.21496478 |
| 66 | MP0002722_abnormal_immune_system | 1.20853019 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.20600085 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.18746208 |
| 69 | MP0002429_abnormal_blood_cell | 1.18221431 |
| 70 | MP0003075_altered_response_to | 1.15881907 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.14489702 |
| 72 | MP0009278_abnormal_bone_marrow | 1.12721219 |
| 73 | MP0001851_eye_inflammation | 1.12394193 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.10680454 |
| 75 | MP0004883_abnormal_blood_vessel | 1.10325281 |
| 76 | MP0005310_abnormal_salivary_gland | 1.09580142 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.09300804 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.08449618 |
| 79 | MP0001835_abnormal_antigen_presentation | 1.07212153 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.06887183 |
| 81 | MP0000685_abnormal_immune_system | 1.06380632 |
| 82 | MP0003866_abnormal_defecation | 1.06059892 |
| 83 | MP0005166_decreased_susceptibility_to | 1.05601424 |
| 84 | MP0005164_abnormal_response_to | 1.04832828 |
| 85 | MP0009764_decreased_sensitivity_to | 1.02770088 |
| 86 | MP0000703_abnormal_thymus_morphology | 1.02277844 |
| 87 | MP0001873_stomach_inflammation | 1.02241973 |
| 88 | MP0004085_abnormal_heartbeat | 1.02161162 |
| 89 | MP0003045_fibrosis | 0.98626574 |
| 90 | MP0000266_abnormal_heart_morphology | 0.98589710 |
| 91 | MP0005623_abnormal_meninges_morphology | 0.98578793 |
| 92 | MP0003091_abnormal_cell_migration | 0.96475543 |
| 93 | MP0002132_abnormal_respiratory_system | 0.96240786 |
| 94 | MP0002108_abnormal_muscle_morphology | 0.95320822 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.95235787 |
| 96 | MP0004381_abnormal_hair_follicle | 0.94336446 |
| 97 | MP0002419_abnormal_innate_immunity | 0.93640695 |
| 98 | MP0001790_abnormal_immune_system | 0.91683742 |
| 99 | MP0005387_immune_system_phenotype | 0.91683742 |
| 100 | MP0000604_amyloidosis | 0.91469011 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.90877453 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.90291562 |
| 103 | MP0001849_ear_inflammation | 0.89286279 |
| 104 | MP0002971_abnormal_brown_adipose | 0.88615697 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.88003298 |
| 106 | MP0002128_abnormal_blood_circulation | 0.87604965 |
| 107 | MP0001533_abnormal_skeleton_physiology | 0.87072502 |
| 108 | MP0005390_skeleton_phenotype | 0.84893565 |
| 109 | MP0005023_abnormal_wound_healing | 0.84449032 |
| 110 | MP0001853_heart_inflammation | 0.83493278 |
| 111 | MP0004147_increased_porphyrin_level | 0.82930879 |
| 112 | MP0009785_altered_susceptibility_to | 0.82079873 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.81491829 |
| 114 | MP0002933_joint_inflammation | 0.81139953 |
| 115 | MP0003690_abnormal_glial_cell | 0.80438106 |
| 116 | MP0002127_abnormal_cardiovascular_syste | 0.79983464 |
| 117 | MP0003795_abnormal_bone_structure | 0.79475879 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 0.79468572 |
| 119 | MP0005025_abnormal_response_to | 0.79276399 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.79190275 |
| 121 | MP0005165_increased_susceptibility_to | 0.78150881 |
| 122 | MP0001545_abnormal_hematopoietic_system | 0.77560525 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.77560525 |
| 124 | MP0005000_abnormal_immune_tolerance | 0.77076856 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.76040591 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.75249134 |
| 127 | MP0001800_abnormal_humoral_immune | 0.74829384 |
| 128 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74776559 |
| 129 | MP0003448_altered_tumor_morphology | 0.74591568 |
| 130 | MP0002166_altered_tumor_susceptibility | 0.74479618 |
| 131 | MP0002877_abnormal_melanocyte_morpholog | 0.74457997 |
| 132 | MP0005503_abnormal_tendon_morphology | 0.73731998 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.73460302 |
| 134 | MP0002148_abnormal_hypersensitivity_rea | 0.71115525 |
| 135 | MP0000249_abnormal_blood_vessel | 0.68743411 |
| 136 | MP0000003_abnormal_adipose_tissue | 0.67622829 |
| 137 | MP0002405_respiratory_system_inflammati | 0.66898707 |
| 138 | MP0004272_abnormal_basement_membrane | 0.65741073 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.64326186 |
| 140 | MP0001819_abnormal_immune_cell | 0.62459538 |
| 141 | MP0003191_abnormal_cellular_cholesterol | 0.62392397 |
| 142 | MP0009115_abnormal_fat_cell | 0.62215193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.62574905 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.52081472 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.49509496 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.42084924 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.37578432 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.19203533 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 5.16213047 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.13835371 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.97523491 |
| 10 | Increased connective tissue (HP:0009025) | 4.97069440 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.86470996 |
| 12 | Ventricular tachycardia (HP:0004756) | 4.57526179 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.54346207 |
| 14 | Nemaline bodies (HP:0003798) | 4.42364793 |
| 15 | Subaortic stenosis (HP:0001682) | 4.32134296 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.32134296 |
| 17 | Difficulty running (HP:0009046) | 4.29774211 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.23198353 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 4.20134208 |
| 20 | Asymmetric septal hypertrophy (HP:0001670) | 4.05465774 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.96422049 |
| 22 | Lipoatrophy (HP:0100578) | 3.96209651 |
| 23 | Myoglobinuria (HP:0002913) | 3.89314402 |
| 24 | Difficulty climbing stairs (HP:0003551) | 3.86358839 |
| 25 | Distal arthrogryposis (HP:0005684) | 3.68638429 |
| 26 | Atrial fibrillation (HP:0005110) | 3.67440722 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.49971734 |
| 28 | Myositis (HP:0100614) | 3.48153079 |
| 29 | Primary atrial arrhythmia (HP:0001692) | 3.43150249 |
| 30 | Round ear (HP:0100830) | 3.41159418 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.35414211 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.34790713 |
| 33 | Rhabdomyolysis (HP:0003201) | 3.32933288 |
| 34 | Supraventricular tachycardia (HP:0004755) | 3.28086695 |
| 35 | Ulnar deviation of the wrist (HP:0003049) | 3.27467291 |
| 36 | Supraventricular arrhythmia (HP:0005115) | 3.25652102 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 3.23862944 |
| 38 | Orchitis (HP:0100796) | 3.17870514 |
| 39 | Dilated cardiomyopathy (HP:0001644) | 3.12378729 |
| 40 | Myotonia (HP:0002486) | 3.10657394 |
| 41 | Distal lower limb amyotrophy (HP:0008944) | 3.10208743 |
| 42 | Myopathic facies (HP:0002058) | 3.00900983 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.97203967 |
| 44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.95456084 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.91765021 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.89125793 |
| 47 | Gingivitis (HP:0000230) | 2.87498039 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.87286594 |
| 49 | Frequent falls (HP:0002359) | 2.85893177 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.85488873 |
| 51 | Increased IgE level (HP:0003212) | 2.82004635 |
| 52 | Neck muscle weakness (HP:0000467) | 2.80583399 |
| 53 | Optic neuritis (HP:0100653) | 2.80335598 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.80335598 |
| 55 | Cellulitis (HP:0100658) | 2.80118156 |
| 56 | Facial diplegia (HP:0001349) | 2.79534475 |
| 57 | Bundle branch block (HP:0011710) | 2.74289821 |
| 58 | Recurrent skin infections (HP:0001581) | 2.74255266 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70278248 |
| 60 | Obstructive lung disease (HP:0006536) | 2.70278248 |
| 61 | Muscle stiffness (HP:0003552) | 2.70269696 |
| 62 | Scapular winging (HP:0003691) | 2.65635227 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.64694209 |
| 64 | Cerebral aneurysm (HP:0004944) | 2.61784105 |
| 65 | Meningitis (HP:0001287) | 2.61117383 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.60595787 |
| 67 | Colitis (HP:0002583) | 2.55274695 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54868943 |
| 69 | Ventricular arrhythmia (HP:0004308) | 2.51070757 |
| 70 | Spinal rigidity (HP:0003306) | 2.51062388 |
| 71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.50716207 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.50716207 |
| 73 | Syncope (HP:0001279) | 2.49922275 |
| 74 | Generalized muscle weakness (HP:0003324) | 2.45148593 |
| 75 | Protrusio acetabuli (HP:0003179) | 2.44915650 |
| 76 | Prolonged QT interval (HP:0001657) | 2.44641541 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.42430369 |
| 78 | Lower limb amyotrophy (HP:0007210) | 2.41653369 |
| 79 | Palpitations (HP:0001962) | 2.40030021 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39542836 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39542836 |
| 82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39542836 |
| 83 | Recurrent viral infections (HP:0004429) | 2.38999357 |
| 84 | Chest pain (HP:0100749) | 2.38315627 |
| 85 | Slender build (HP:0001533) | 2.37215567 |
| 86 | Inflammation of the large intestine (HP:0002037) | 2.37205586 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.35701315 |
| 88 | Abnormal atrioventricular conduction (HP:0005150) | 2.34267536 |
| 89 | Prolonged bleeding time (HP:0003010) | 2.34029373 |
| 90 | Vasculitis (HP:0002633) | 2.32289024 |
| 91 | Urticaria (HP:0001025) | 2.32060110 |
| 92 | Stomatitis (HP:0010280) | 2.31356368 |
| 93 | Limb-girdle muscle atrophy (HP:0003797) | 2.31180823 |
| 94 | Areflexia of lower limbs (HP:0002522) | 2.29577781 |
| 95 | Increased density of long bones (HP:0006392) | 2.28260753 |
| 96 | Calcaneovalgus deformity (HP:0001848) | 2.27850802 |
| 97 | Heart block (HP:0012722) | 2.26403114 |
| 98 | Gowers sign (HP:0003391) | 2.21756321 |
| 99 | Pustule (HP:0200039) | 2.21741499 |
| 100 | Amyloidosis (HP:0011034) | 2.21480193 |
| 101 | Atrioventricular block (HP:0001678) | 2.21442392 |
| 102 | Keratoconjunctivitis sicca (HP:0001097) | 2.18539016 |
| 103 | Hypoplastic ischia (HP:0003175) | 2.13538369 |
| 104 | Malignant hyperthermia (HP:0002047) | 2.13161836 |
| 105 | Increased cerebral lipofuscin (HP:0011813) | 2.12969071 |
| 106 | EMG: neuropathic changes (HP:0003445) | 2.11200265 |
| 107 | Increased serum ferritin (HP:0003281) | 2.10698650 |
| 108 | Epistaxis (HP:0000421) | 2.10686194 |
| 109 | Malnutrition (HP:0004395) | 2.10253154 |
| 110 | Dysostosis multiplex (HP:0000943) | 2.07877237 |
| 111 | Deformed tarsal bones (HP:0008119) | 2.07295423 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 2.07091382 |
| 113 | Broad metatarsal (HP:0001783) | 2.06132943 |
| 114 | Encephalitis (HP:0002383) | 2.05308707 |
| 115 | Osteomyelitis (HP:0002754) | 2.05129589 |
| 116 | Muscular dystrophy (HP:0003560) | 2.04621269 |
| 117 | Aortic aneurysm (HP:0004942) | 2.04040616 |
| 118 | Abnormality of the neuromuscular junction (HP:0003398) | 2.03291139 |
| 119 | Fatigable weakness (HP:0003473) | 2.03291139 |
| 120 | Hemoptysis (HP:0002105) | 2.02156139 |
| 121 | Pulmonary infiltrates (HP:0002113) | 1.97859381 |
| 122 | Recurrent abscess formation (HP:0002722) | 1.96850231 |
| 123 | Aortic dissection (HP:0002647) | 1.95324005 |
| 124 | Hip contracture (HP:0003273) | 1.95199283 |
| 125 | Absent phalangeal crease (HP:0006109) | 1.94613036 |
| 126 | Fatigue (HP:0012378) | 1.93805274 |
| 127 | Bulbar palsy (HP:0001283) | 1.93146784 |
| 128 | Gingival bleeding (HP:0000225) | 1.91394301 |
| 129 | Arterial thrombosis (HP:0004420) | 1.91257272 |
| 130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.90996856 |
| 131 | Keratoconjunctivitis (HP:0001096) | 1.89177493 |
| 132 | Ankle contracture (HP:0006466) | 1.88822803 |
| 133 | Gastrointestinal stroma tumor (HP:0100723) | 1.88496365 |
| 134 | Loss of speech (HP:0002371) | 1.86848446 |
| 135 | Interstitial pulmonary disease (HP:0006530) | 1.86198034 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 1.84172806 |
| 137 | Eczematoid dermatitis (HP:0000976) | 1.83943542 |
| 138 | Wrist flexion contracture (HP:0001239) | 1.83692164 |
| 139 | Abnormality of the calcaneus (HP:0008364) | 1.83409275 |
| 140 | Abnormality of the fingertips (HP:0001211) | 1.83348631 |
| 141 | Testicular atrophy (HP:0000029) | 1.83336865 |
| 142 | Cholelithiasis (HP:0001081) | 1.81164276 |
| 143 | Spondylolisthesis (HP:0003302) | 1.80403398 |
| 144 | Restrictive lung disease (HP:0002091) | 1.79083455 |
| 145 | Abnormality of the peritoneum (HP:0002585) | 1.78225417 |
| 146 | Hypochromic anemia (HP:0001931) | 1.76967319 |
| 147 | Emphysema (HP:0002097) | 1.75660463 |
| 148 | Abnormality of the ischium (HP:0003174) | 1.75561467 |
| 149 | Weak cry (HP:0001612) | 1.75384543 |
| 150 | T lymphocytopenia (HP:0005403) | 1.74918588 |
| 151 | Reticulocytosis (HP:0001923) | 1.74779036 |
| 152 | Broad face (HP:0000283) | 1.74011808 |
| 153 | Easy fatigability (HP:0003388) | 1.73824852 |
| 154 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73447538 |
| 155 | Proximal amyotrophy (HP:0007126) | 1.72641092 |
| 156 | Obstructive sleep apnea (HP:0002870) | 1.72339096 |
| 157 | Thin bony cortex (HP:0002753) | 1.72084463 |
| 158 | Dilatation of the ascending aorta (HP:0005111) | 1.71989113 |
| 159 | Myocardial infarction (HP:0001658) | 1.71772864 |
| 160 | Abnormality of the endocardium (HP:0004306) | 1.71351317 |
| 161 | Peritonitis (HP:0002586) | 1.70820599 |
| 162 | Limb-girdle muscle weakness (HP:0003325) | 1.69689099 |
| 163 | Abnormality of the foot musculature (HP:0001436) | 1.68824807 |
| 164 | Conjunctival hamartoma (HP:0100780) | 1.67132153 |
| 165 | Polycythemia (HP:0001901) | 1.66140725 |
| 166 | Sudden cardiac death (HP:0001645) | 1.64451403 |
| 167 | Rimmed vacuoles (HP:0003805) | 1.64090009 |
| 168 | Axonal loss (HP:0003447) | 1.63678910 |
| 169 | Abnormal EKG (HP:0003115) | 1.63622917 |
| 170 | Foot dorsiflexor weakness (HP:0009027) | 1.63224403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.24484701 |
| 2 | OBSCN | 4.37790710 |
| 3 | TRIB3 | 4.05523638 |
| 4 | PRPF4B | 3.42274602 |
| 5 | PKN2 | 3.26008468 |
| 6 | DMPK | 2.69972018 |
| 7 | PHKG2 | 2.34863274 |
| 8 | PHKG1 | 2.34863274 |
| 9 | MYLK | 2.17022593 |
| 10 | MAP3K13 | 2.05769710 |
| 11 | MAP2K3 | 1.91275363 |
| 12 | PDK3 | 1.84662012 |
| 13 | PDK4 | 1.84662012 |
| 14 | PIK3CA | 1.83989073 |
| 15 | PIK3CG | 1.78756220 |
| 16 | TRPM7 | 1.74588174 |
| 17 | ERN1 | 1.65569403 |
| 18 | LMTK2 | 1.60015899 |
| 19 | TGFBR2 | 1.48744249 |
| 20 | MAP4K1 | 1.47647210 |
| 21 | TNK2 | 1.47330226 |
| 22 | MAP3K10 | 1.43340337 |
| 23 | RIPK1 | 1.37137889 |
| 24 | FES | 1.36578656 |
| 25 | TBK1 | 1.33572022 |
| 26 | GRK6 | 1.29650810 |
| 27 | TIE1 | 1.29436780 |
| 28 | FGR | 1.28547749 |
| 29 | TAOK2 | 1.27873214 |
| 30 | MAP3K1 | 1.27806632 |
| 31 | STK24 | 1.26753266 |
| 32 | TYK2 | 1.25795451 |
| 33 | SMG1 | 1.23607105 |
| 34 | EPHB1 | 1.19080870 |
| 35 | MARK2 | 1.18598196 |
| 36 | PDK2 | 1.17524420 |
| 37 | FGFR4 | 1.14904631 |
| 38 | KSR2 | 1.14084440 |
| 39 | EEF2K | 1.12583487 |
| 40 | CAMK1D | 1.11785635 |
| 41 | MUSK | 1.11649296 |
| 42 | JAK1 | 1.10000147 |
| 43 | ILK | 1.08925973 |
| 44 | PTK6 | 1.06323710 |
| 45 | MAPK12 | 1.04891748 |
| 46 | CDK12 | 1.03461520 |
| 47 | NEK9 | 1.03187922 |
| 48 | PTK2B | 1.01455851 |
| 49 | STK4 | 0.98342420 |
| 50 | PRKD2 | 0.97676973 |
| 51 | LRRK2 | 0.96343669 |
| 52 | KIT | 0.95416436 |
| 53 | JAK3 | 0.94618880 |
| 54 | BLK | 0.94107131 |
| 55 | SIK3 | 0.93966862 |
| 56 | MAP3K3 | 0.93469279 |
| 57 | MAP3K7 | 0.92873560 |
| 58 | MAP3K6 | 0.91519750 |
| 59 | MAPKAPK3 | 0.90922209 |
| 60 | NME2 | 0.89767380 |
| 61 | CAMK1G | 0.89304070 |
| 62 | MAPK7 | 0.88063403 |
| 63 | ZAK | 0.85497387 |
| 64 | PRKAA2 | 0.83906687 |
| 65 | PDGFRA | 0.82677762 |
| 66 | FLT3 | 0.82276283 |
| 67 | STK10 | 0.82253908 |
| 68 | PRKD1 | 0.81472652 |
| 69 | SIK1 | 0.79913146 |
| 70 | NEK1 | 0.79849700 |
| 71 | LYN | 0.79183864 |
| 72 | CSF1R | 0.79005173 |
| 73 | BMX | 0.77741434 |
| 74 | LCK | 0.75225556 |
| 75 | HCK | 0.74889685 |
| 76 | DAPK3 | 0.74713620 |
| 77 | KDR | 0.71946790 |
| 78 | IRAK2 | 0.71570635 |
| 79 | FGFR3 | 0.70879769 |
| 80 | TXK | 0.68519110 |
| 81 | ROCK1 | 0.66988121 |
| 82 | CSK | 0.66587974 |
| 83 | MATK | 0.66164424 |
| 84 | HIPK2 | 0.65265467 |
| 85 | ZAP70 | 0.65031161 |
| 86 | GRK7 | 0.63486972 |
| 87 | PAK2 | 0.62411394 |
| 88 | MOS | 0.62095672 |
| 89 | MAP3K5 | 0.61130341 |
| 90 | IRAK1 | 0.60701912 |
| 91 | MST1R | 0.58141364 |
| 92 | MAP3K14 | 0.57501902 |
| 93 | TESK1 | 0.57116015 |
| 94 | PRKAA1 | 0.56164233 |
| 95 | RIPK4 | 0.55490266 |
| 96 | SGK3 | 0.55257269 |
| 97 | ITK | 0.55207945 |
| 98 | RPS6KC1 | 0.53943904 |
| 99 | RPS6KL1 | 0.53943904 |
| 100 | IKBKB | 0.53632076 |
| 101 | RPS6KA6 | 0.53174416 |
| 102 | CDC42BPA | 0.52841412 |
| 103 | YES1 | 0.52243487 |
| 104 | TAOK1 | 0.51590323 |
| 105 | MAP3K11 | 0.50898810 |
| 106 | PDPK1 | 0.50775361 |
| 107 | BMPR2 | 0.49484263 |
| 108 | RPS6KA4 | 0.48521172 |
| 109 | PAK4 | 0.47989100 |
| 110 | SYK | 0.47902287 |
| 111 | MAPKAPK2 | 0.46875764 |
| 112 | JAK2 | 0.46760244 |
| 113 | MTOR | 0.46515762 |
| 114 | PRKG2 | 0.46385667 |
| 115 | MAP3K2 | 0.45987599 |
| 116 | DYRK1B | 0.45604616 |
| 117 | IRAK3 | 0.44933459 |
| 118 | RET | 0.44595415 |
| 119 | BCKDK | 0.44456159 |
| 120 | CDK4 | 0.43824643 |
| 121 | IKBKE | 0.43615179 |
| 122 | PDK1 | 0.43142851 |
| 123 | TESK2 | 0.42676609 |
| 124 | MARK3 | 0.42565264 |
| 125 | DDR2 | 0.42539484 |
| 126 | ICK | 0.40840237 |
| 127 | PIM2 | 0.40833111 |
| 128 | MAP2K6 | 0.40496620 |
| 129 | CDK6 | 0.40041078 |
| 130 | MAP3K8 | 0.39942869 |
| 131 | FYN | 0.39364230 |
| 132 | RPS6KA2 | 0.39076947 |
| 133 | NME1 | 0.38833027 |
| 134 | IRAK4 | 0.38435260 |
| 135 | MAPK11 | 0.38015854 |
| 136 | SIK2 | 0.37529104 |
| 137 | BTK | 0.36881966 |
| 138 | STK3 | 0.35937829 |
| 139 | AKT2 | 0.34505105 |
| 140 | MAP2K1 | 0.33855962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.75204571 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.58163561 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.51295339 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.71245165 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.49076891 |
| 6 | Viral myocarditis_Homo sapiens_hsa05416 | 2.44496132 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.05990174 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78334941 |
| 9 | Focal adhesion_Homo sapiens_hsa04510 | 1.70302265 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.68440070 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67401079 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62644995 |
| 13 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.53673151 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51719455 |
| 15 | Insulin resistance_Homo sapiens_hsa04931 | 1.50051829 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41353281 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.39939102 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36776945 |
| 19 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.35131968 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35086972 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33830971 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.32599242 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32048308 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31732438 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.26794401 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26141206 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.26084562 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.25268325 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.25026342 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23917694 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22247641 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21105808 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.19961166 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19652608 |
| 35 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.19130193 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18624310 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13236873 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12004706 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.11228583 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.09427797 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.08932805 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04981782 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04427803 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03833271 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03793411 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03683475 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03607252 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.00793622 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.00699350 |
| 50 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99154466 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98601462 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97870890 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97246607 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96843070 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96419404 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96138543 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.94994634 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.94501130 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.94382438 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93837858 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92937095 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92246260 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91825327 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91187029 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90583960 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89923774 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.89335852 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85683379 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85363816 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84924762 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84878073 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83549853 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83380704 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80922201 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80556082 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.80450496 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79763475 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77596282 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77476124 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.77196371 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76910581 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76162716 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73922726 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73276057 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71768243 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71595681 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70814897 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69540476 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.68861745 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.68068340 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67192790 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66451089 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.65880129 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65488104 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64612456 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64235081 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63747370 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62790426 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62382885 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.62193514 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.61141111 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.60288625 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60237823 |
| 104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59987485 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59396787 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.59067869 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58870169 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58548248 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57618171 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.57437607 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57365973 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57110055 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.56513849 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55310629 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55103177 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54065038 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54055634 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.53374696 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53348010 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53212723 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52808835 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52308419 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51719194 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51643355 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51453405 |
| 126 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50774719 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50335606 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.50335427 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47906003 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46958338 |
| 131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46312169 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45669768 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45213151 |
| 134 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44009938 |
| 135 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43582188 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43184719 |

